Given the lower enzymatic activity in individuals with the variant TT genotype of MTHFR C677T, a key enzyme in the folate metabolizing pathway, we hypothesized that the TT genotype carriers have an increased risk of pancreatic cancer. This evidence concerns the gene MTHFR and pancreatic neoplasm.